Older children with immune thrombocytopenia (ITP) who had had an infection tended to achieve sufficient levels of platelets —…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsCombo of blood biomarkers can help predict risk of death in TTP
A combination of blood biomarkers can help predict the short-term risk of death for people admitted to the hospital with…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsLupus may alter iTTP symptoms, outcomes: Study
People with immune-mediated thrombotic thrombocytopenic purpura (iTTP) who also have systemic lupus erythematosus (SLE) — have different symptoms and…
IMMUNE THROMBOCYTOPENIA
NewsBoosting platelet counts in ITP is aim of efgartigimod study
A Phase 3 trial testing efgartigimod administered into a vein in adults with primary immune thrombocytopenia (ITP) is still…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsDiagnosing, treating TTP promptly improves pregnancy outcomes
Acquired thrombotic thrombocytopenic purpura (TTP) during pregnancy must be distinguished from other conditions, monitored carefully, and treated promptly to…
IMMUNE THROMBOCYTOPENIA
NewsDoptelet found safe, effective in previously treated children with ITP
Doptelet (avatrombopag) was safe and effective in children with immune thrombocytopenia (ITP) who had an insufficient response to…